Seeking Alpha

Humana Inc. (HUM)

  • Sep. 25, 2013, 3:08 AM
    • The average cost of a mid-tier health insurance plan under Obamacare is $328 a month, price data from the government showed yesterday, just a week before enrollment in the healthcare overhaul is due to begin on October 1.
    • As you'd expect, prices were cheaper in the states with more competition.
    • The Obama administration hopes to sign up 7M consumers in the first year, with 2.7M young and healthy Americans set to pay for those who are older and sicker. The average premium for a 27-year-old nonsmoker will range from $163-$240 a month.
    • Health insurers that intend to sell plans on some exchanges include UnitedHealth (UNH), Aetna (AET), WellPoint (WLP) and Humana (HUM). Molina Healthcare (MOH) is also set to play a role.
  • Aug. 29, 2013, 12:26 PM
    • Eli Lilly (LLY +0.1%) and Humana (HUM +0.9%) enter into a multi-year research agreement aimed at improving health care quality.
    • The project is aimed at investigating patient characteristics associated with increased health care costs in people with type 2 diabetes.
    | Comment!
  • Aug. 28, 2013, 10:19 AM
    • The Department of Health & Human Services (HHS) has reportedly delayed the signing of final agreements with insurance plans that are to be sold on health insurance exchanges starting on October 1.
    • The HHS intends to sign the plans - which are a crucial part of Obamacare - in mid-September rather than from September 5-9, as previously intended. The reasons for the delay aren't clear.
    • The HHS says it's "on track to open" the marketplaces on time on October 1, although the delay raises doubts about whether that's the case.
    • "Having everything ready on October 1 is not a critical issue," says an administration official who worked on Obamacare. "What matters to people is January 1, which is when the coverage is supposed to start. If that were delayed, it would be a substantive setback.
    • Related tickers: AET, UNH, HNT, CI, WLP, UAM, HUM, MOH, CNC, CVH, MGLN
  • Aug. 22, 2013, 5:34 PM
    • Humana Inc. (HUM) declares $0.27/share quarterly dividend, in line with previous.
    • Forward yield 1.16%
    • Payable Oct. 25; for shareholders of record Sept. 30; ex-div Sept. 26.
    | Comment!
  • Aug. 15, 2013, 3:22 PM
    • Many health insurers are gearing up to limit the choices of doctors and hospitals they'll cover. Why? The cost.
    • Smaller networks of providers generally translate to lower premiums, because insurers can negotiate discounts with health-care providers who will then have less competition for patients within the network.
    • Insurers are betting that consumers who buy plans on the exchanges will be willing to trade some choice and flexibility in order to get cheaper premiums.
    • The backlash is that consumers will generally have to pay the cost out of his own pocket if they want to see physicians outside the system.
  • Aug. 15, 2013, 12:54 PM
    • Humana (HUM -1.4%) "has managed to skyrocket despite uncertainty surrounding Obamacare. Betting against it now based on legislative risk doesn't make sense to me given the valuation," InsiderInsights' Jonathan Moreland says, downplaying insider selling in the shares reported by Barron's.
    • All told, three executives have sold a total of 52K shares from August 7-13.
    • CFO James Bloem sold 33K shares for $3.029M.
    • HUM is trading near its 52-week high of $94.14.
    | Comment!
  • Jul. 31, 2013, 9:05 AM
    • Humana (HUM +1.5%) net profit +18% to $420M.
    • Revenue +6.4% to $10.3B, as expected.
    • Medicare Advantage membership +7% to over 2M, premiums and services revenue in retail segment +6% to $6.8B.
    • Medicare prescription drug plans membership +8.5% to 3.2M.
    • Enrollment +16% to 416,600 in Humana's employer-sponsored, group Medicare Advantage plans
    • Spent 83.4% of premiums on medical benefits, down from 83.5% last year.
    • Total medical membership 12.37M; 8.27M in dental, vision and other supplemental benefit plans.
    • Increases FY EPS guidance to $8.65-8.75 from prior outlook of $8.40-8.60 and vs consensus of $8.68. (Previous)
    | Comment!
  • Jul. 31, 2013, 6:03 AM
    • Humana (HUM): Q2 EPS of $2.63 beats by $0.16. (PR)
    | Comment!
  • Jul. 31, 2013, 12:05 AM
  • Jul. 30, 2013, 5:30 PM
  • Jul. 16, 2013, 2:39 PM
    It's all about management's commentary on EPS growth for managed care stocks, Deutsche's Scott Fidel says, noting that investors are already "expecting strong quarterly results based on continued subdued health care utilization trends." Watch the "tone" on the CCs for hints about the prospects for earnings in 2014 and "key revenue and margin drivers," Fidel adds. Price targets are hiked for Aetna (AET -1.8%), Cigna (CI -1.5%), Magellan Health (MGLN -0.3%), Health Net (HNT -1.1%), UnitedHealth (UNH -1.2%), WellPoint (WLP -0.4%), Humana (HUM +0.1%), Universal American (UAM -0.8%), Centene (CNC +0.6%) Molina (MOH +0.7%), WellCare Health Plans (WCG +1.1%), eHealth (EHTH -3%), and Healthways (HWAY -1.9%).
    | Comment!
  • Jul. 3, 2013, 8:41 AM
    Some health insurers are suffering moderate losses premarket following the government's decision to delay a rule that requires companies with more than 50 workers to provide health coverage, although many appear to be untraded at the moment. Aetna (AET) -1.1%, UnitedHealth (UNH) -1.2% and Humana (HUM) -0.3%.
    | Comment!
  • May 22, 2013, 5:48 PM
    After-hours top gainers, as of 5:30 p.m.: PSUN +17.8%. HPQ +13.8%. NCS +7.6%. RTIX +5.8%. AMAG +5.6%.
    After-hours top losers: VICL -3.2%. CST -2.8%. SYPR -2.4%. HUM -1.8%. NG -1.8%.
    | Comment!
  • May 16, 2013, 1:55 PM
    Quest Diagnostics (DGX +0.3%) moves to expand its lab business by acquiring the toxicology and clinical laboratory business of Concentra, a medical center operator owned by Humana (HUM). The business will be transitioned into DGX's national laboratory network of regional clinical and toxicology laboratories by the end of 2013. The the company also entered into a long-term agreement with Concentra to be its primary provider of workplace drug toxicology and clinical lab testing.
    | Comment!
  • May 8, 2013, 3:33 PM
    Shares of Humana (HUM +2.2%) gain today after the company says it plans to add approximately 500 Telesales Specialists and leadership jobs nationally to its full-time Direct Marketing Services Telesales workforce, to meet demand for the upcoming annual Medicare open enrollment period.
    | Comment!
  • May 6, 2013, 8:25 AM
    Humana (HUM) gets an upgrade from JPMorgan to Overweight from Neutral (price target $91 from $88) following last week's beat and raise. "What's a reasonable [minimum] return on invested capital metric that we should think about for the Medicare Advantage business?" analyst Justin Lake asked on the call. 13% "is the number that it is today [and] we expect to improve on it, but not in a predictive sense," management responded. Shares +0.91% premarket. (transcript)
    | Comment!
Visit Seeking Alpha's
HUM vs. ETF Alternatives
Company Description
Humana Inc is a health care company that offers a insurance products and health and wellness services. Its segments include Retail, Employer Group, and Healthcare Services.
Sector: Healthcare
Country: United States